Akebia Therapeutics CEO On Controlling Anemia Safely By: Benzinga via Benzinga September 28, 2015 at 14:36 PM EDT Akebia Therapeutics Inc (NASDAQ: AKBA) is developing a safer treatment for anemia in patients with Chronic Kidney Disease. The ... Read More >> Related Stocks: Akebia Therapeutics